Results 41 to 50 of about 3,222 (181)

Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases

open access: yesNeuroprotection, Volume 3, Issue 2, Page 120-130, June 2025.
The abstract depicts the gut‐brain axis, illustrating the bidirectional communication between the gastrointestinal tract and the central nervous system. Probiotics can induce the production of neurotrophins, neurotransmitters, SCFAs, and contribute to increased antioxidant levels, which can benefit brain health. In contrast, antibiotics can disrupt the
Tobiloba S. Olajide   +1 more
wiley   +1 more source

Pseudomembranosa colitis: apropos of a case

open access: yesArchivo Médico de Camagüey, 2019
Background: pseudomembranous colitis is a disease caused by Clostridium difficile in recent times has attracted the attention of the medical community, due to an increase in the incidence in health institutions, as well as in the community, motivated by ...
Kiopper Tartabull-Poutriel   +2 more
doaj  

Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
This article reviews the use of fecal microbiota transplantation (FMT) to treat intestinal diseases like recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS). It discusses FMT's efficacy, influencing factors such as donor selection, recipient characteristics, and treatment protocols ...
Shuna Hou   +4 more
wiley   +1 more source

The Simple Predictors of Pseudomembranous Colitis in Patients with Hospital-Acquired Diarrhea: A Prospective Observational Study

open access: yesGut and Liver, 2014
Background/AimsAs the incidence rate of and mortality from pseudomembranous colitis (PMC) are increasing worldwide, it is important to study the simple predictive risk factors for PMC among patients with hospital-acquired diarrhea (HAD).
doaj   +1 more source

Multi-detector computed tomography of acute abdomen [PDF]

open access: yes, 2018
Acute abdominal pain is one of the most common causes for referrals to the emergency department. The sudden onset of severe abdominal pain characterising the "acute abdomen” requires rapid and accurate identification of a potentially life-threatening ...
Alkadhi, Hatem   +3 more
core  

Соеви на Clostridium difficile асоцирани со нозокомијални инфекции –лабораториска дијагноза, преваленца, осетливост и молекуларна карактеризација на изолатите [PDF]

open access: yes, 2015
Although there was not much attention about the role of this bacterium in the past, Clostridium difficile is one of the most important agents associated with nosocomial infections today. The main reason for this is its resistance against many antibiotics
Mihajlov, Kiril   +1 more
core   +2 more sources

Role of microbiota in pain: From bench to bedside

open access: yesiMetaOmics, Volume 2, Issue 1, March 2025.
Pain is closely linked to microbes. The microbiota modulates pain perception through three mechanisms: microbiota‐derived metabolites, immunoregulation, and direct stimulation on neurons. Therapeutic strategies like probiotics, fecal microbiota transplantation, and dietary changes show significant potential in pain management.
Huiguang Ren   +5 more
wiley   +1 more source

The Spectrum of Pseudomembranous Enterocolitis and Antibiotic-Associated Diarrhea [PDF]

open access: yesArchives of Internal Medicine, 2002
Pseudomembranous (entero)colitis is primarily caused by Clostridium difficile infection. The most common predisposing factor is prior use of antibiotics, including vancomycin and metronidazole, which themselves are therapy for C difficile colitis. Other risk factors have also been described.
Cuong C. Nguyen, Brian W. Hurley
openaire   +3 more sources

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro‐Oesophageal Reflux Disease or Erosive Oesophagitis

open access: yesAlimentary Pharmacology &Therapeutics, Volume 61, Issue 5, Page 835-851, March 2025.
The safety of vonoprazan was evaluated in an integrated analysis of data from clinical trials and post‐marketing experience in adults with symptomatic gastro‐oesophageal reflux disease or erosive oesophagitis. Vonoprazan was well tolerated, with a similar safety profile to proton pump inhibitor comparators.
Colin W. Howden   +8 more
wiley   +1 more source

UEG Week 2023 Poster Presentations

open access: yes, 2023
United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley   +1 more source

Home - About - Disclaimer - Privacy